PL3076996T3 - Szczepionka przeciwko cirkowirusowi świń typu 2 - Google Patents
Szczepionka przeciwko cirkowirusowi świń typu 2Info
- Publication number
- PL3076996T3 PL3076996T3 PL14805617T PL14805617T PL3076996T3 PL 3076996 T3 PL3076996 T3 PL 3076996T3 PL 14805617 T PL14805617 T PL 14805617T PL 14805617 T PL14805617 T PL 14805617T PL 3076996 T3 PL3076996 T3 PL 3076996T3
- Authority
- PL
- Poland
- Prior art keywords
- virus type
- vaccine against
- against porcine
- circo virus
- porcine circo
- Prior art date
Links
- 241001673669 Porcine circovirus 2 Species 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13195515 | 2013-12-03 | ||
| EP14805617.9A EP3076996B1 (en) | 2013-12-03 | 2014-12-02 | Vaccine against porcine circo virus type 2 |
| PCT/EP2014/076224 WO2015082458A1 (en) | 2013-12-03 | 2014-12-02 | Vaccine against porcine circo virus type 2 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3076996T3 true PL3076996T3 (pl) | 2020-05-18 |
Family
ID=49680926
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL14805617T PL3076996T3 (pl) | 2013-12-03 | 2014-12-02 | Szczepionka przeciwko cirkowirusowi świń typu 2 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US10130698B2 (pl) |
| EP (1) | EP3076996B1 (pl) |
| JP (1) | JP6605469B2 (pl) |
| KR (1) | KR20160093047A (pl) |
| CN (2) | CN105848675A (pl) |
| BR (1) | BR112016012435A8 (pl) |
| CA (1) | CA2931137C (pl) |
| DK (1) | DK3076996T3 (pl) |
| ES (1) | ES2771899T3 (pl) |
| MX (1) | MX369039B (pl) |
| PL (1) | PL3076996T3 (pl) |
| RU (1) | RU2712155C2 (pl) |
| WO (1) | WO2015082458A1 (pl) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2931137C (en) | 2013-12-03 | 2023-03-14 | Intervet International B.V. | Vaccine against porcine circo virus type 2 |
| KR102748051B1 (ko) * | 2015-10-22 | 2024-12-27 | 인터벳 인터내셔널 비.브이. | 로소니아 인트라셀룰라리스에 의한 감염으로 발생하는 장애로부터 mda 양성 동물을 보호하기 위한 백신 |
| JP7558638B2 (ja) * | 2016-03-23 | 2024-10-01 | インターベット インターナショナル ベー． フェー． | Ｐｃｖ２およびｐｒｒｓウイルス感染に対する皮内適用のためのワクチン |
| JP7665289B2 (ja) * | 2017-04-13 | 2025-04-21 | インターベット インターナショナル ベー． フェー． | 組合せ非混合使用のためのブタ病原体含有ワクチン |
| WO2022186661A1 (ko) * | 2021-03-04 | 2022-09-09 | 주식회사 이노백 | 돼지 마이코플라스마균 및 돼지 써코바이러스 감염 예방을 위한 다가 백신 조성물 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000502054A (ja) | 1995-11-30 | 2000-02-22 | アグリカルチャー ビクトリア サービシーズ ピーティーワイ．エルティーディー． | 治療用および診断用の組成物 |
| FR2781159B1 (fr) * | 1998-07-06 | 2000-10-06 | Merial Sas | Vaccin circovirus et parvovirus porcin |
| US7276353B2 (en) | 2001-12-12 | 2007-10-02 | Virginia Tech Intellectual Properties, Inc. | Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof |
| ATE392905T1 (de) | 2003-07-24 | 2008-05-15 | Merial Ltd | Vakzin-formulierungen mit einer öl-in-wasser- emulsion |
| BRPI0507017A (pt) | 2004-01-22 | 2007-06-05 | Intervet Int Bv | ácido nucleico que codifica uma proteìna de lawsonia intracellularis, fragmento de dna, molécula de dna recombinante, carreador recombinante vivo, célula hospedeira, proteìna de lawsonia intracellularis, uso da mesma, vacina para combater as infecções por lawsonia intracellularis, método para preparação da mesma, e, teste de diagnóstico |
| US7833707B2 (en) * | 2004-12-30 | 2010-11-16 | Boehringer Ingelheim Vetmedica, Inc. | Methods of overexpression and recovery of porcine circovirus type 2 ORF2 |
| US7691368B2 (en) | 2005-04-15 | 2010-04-06 | Merial Limited | Vaccine formulations |
| DK1926496T3 (da) * | 2005-09-09 | 2013-09-30 | Intervet Int Bv | PCV-2-vaccine |
| MX338626B (es) | 2005-12-29 | 2016-04-26 | Boehringer Ingelheim Vetmed | Uso de una composicion inmunogenica de pcv2 para producir los sintomas clinicos en cerdos. |
| EP2859900A1 (en) | 2006-12-11 | 2015-04-15 | Boehringer Ingelheim Vetmedica, Inc. | Effective method of treatment of porcine circovirus and lawsonia intracellularis infections |
| BRPI0721083A2 (pt) | 2006-12-15 | 2014-02-25 | Boehringer Ingelheim Vetmed | Tratamento de porcos com antígeno de pcv2 |
| EP1958644A1 (en) | 2007-02-13 | 2008-08-20 | Boehringer Ingelheim Vetmedica Gmbh | Prevention and treatment of sub-clinical pcvd |
| JP5613061B2 (ja) * | 2008-01-23 | 2014-10-22 | ベーリンガー インゲルハイム フェトメディカ インコーポレイテッド | Ｐｃｖ２マイコプラズマ・ハイオニューモニエ免疫原性組成物および前記組成物の製造方法 |
| TWI449533B (zh) * | 2008-04-18 | 2014-08-21 | Intervet Int Bv | 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）、豬肺炎黴漿菌（Ｍｙｃｏｐｌａｓｍａ ｈｙｏｐｎｅｕｍｏｎｉａｅ）及豬環狀病毒（Ｐｏｒｃｉｎｅ ｃｉｒｃｏ ｖｉｒｕｓ）用疫苗 |
| TWI551295B (zh) | 2008-04-18 | 2016-10-01 | 英特威特國際股份有限公司 | 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）用疫苗 |
| UA114504C2 (uk) | 2012-04-04 | 2017-06-26 | Зоетіс Сервісіз Ллс | Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs |
| UA114503C2 (uk) * | 2012-04-04 | 2017-06-26 | Зоетіс Сервісіз Ллс | Комбінована вакцина pcv та mycoplasma hyopneumoniae |
| CA2931137C (en) | 2013-12-03 | 2023-03-14 | Intervet International B.V. | Vaccine against porcine circo virus type 2 |
| EP3076995B1 (en) | 2013-12-03 | 2020-03-11 | Intervet International B.V. | Vaccine against lawsonia intracellularis and porcine circovirus 2 |
-
2014
- 2014-12-02 CA CA2931137A patent/CA2931137C/en active Active
- 2014-12-02 ES ES14805617T patent/ES2771899T3/es active Active
- 2014-12-02 KR KR1020167017419A patent/KR20160093047A/ko not_active Ceased
- 2014-12-02 CN CN201480066507.5A patent/CN105848675A/zh active Pending
- 2014-12-02 MX MX2016007224A patent/MX369039B/es active IP Right Grant
- 2014-12-02 PL PL14805617T patent/PL3076996T3/pl unknown
- 2014-12-02 BR BR112016012435A patent/BR112016012435A8/pt not_active Application Discontinuation
- 2014-12-02 RU RU2016126392A patent/RU2712155C2/ru active
- 2014-12-02 WO PCT/EP2014/076224 patent/WO2015082458A1/en not_active Ceased
- 2014-12-02 CN CN201910822557.6A patent/CN110354258A/zh active Pending
- 2014-12-02 DK DK14805617.9T patent/DK3076996T3/da active
- 2014-12-02 US US15/038,765 patent/US10130698B2/en active Active
- 2014-12-02 JP JP2016535652A patent/JP6605469B2/ja active Active
- 2014-12-02 EP EP14805617.9A patent/EP3076996B1/en not_active Revoked
Also Published As
| Publication number | Publication date |
|---|---|
| US10130698B2 (en) | 2018-11-20 |
| RU2712155C2 (ru) | 2020-01-24 |
| KR20160093047A (ko) | 2016-08-05 |
| JP6605469B2 (ja) | 2019-11-13 |
| BR112016012435A2 (pt) | 2017-08-08 |
| US20170157236A1 (en) | 2017-06-08 |
| BR112016012435A8 (pt) | 2018-01-30 |
| WO2015082458A1 (en) | 2015-06-11 |
| JP2017501984A (ja) | 2017-01-19 |
| ES2771899T3 (es) | 2020-07-07 |
| MX369039B (es) | 2019-10-25 |
| CA2931137C (en) | 2023-03-14 |
| DK3076996T3 (en) | 2020-03-09 |
| CN110354258A (zh) | 2019-10-22 |
| EP3076996A1 (en) | 2016-10-12 |
| CN105848675A (zh) | 2016-08-10 |
| EP3076996B1 (en) | 2020-01-15 |
| CA2931137A1 (en) | 2015-06-11 |
| MX2016007224A (es) | 2016-07-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL276210A (en) | MERS-COV vaccine | |
| IL279395A (en) | A vaccine | |
| SG11201507883SA (en) | Wt1-antigen peptide conjugate vaccine | |
| PL3077519T3 (pl) | Szczepionki CMV | |
| GB201321242D0 (en) | Immunogenic compound | |
| EP2806891A4 (en) | VACCINES BASED ON PARAINFLUENZA VIRUS 5 | |
| EP2974740A4 (en) | HEPATITIS B VACCINE | |
| GB201304837D0 (en) | Implant trialling | |
| IL241271A (en) | Al-Thai pertussis vaccine | |
| GB201301085D0 (en) | Glycoconjugate Vaccine | |
| GB201304835D0 (en) | Implant trialling | |
| SG11201510617WA (en) | Methods and compositions for dengue virus vaccines | |
| SG11201505930TA (en) | Porcine parvovirus 5b, methods of use and vaccine | |
| PL2958935T3 (pl) | Szczepionka | |
| GB201309664D0 (en) | Fish vaccine | |
| ZA201507770B (en) | Composition with reduced immunogenicity | |
| EP2968394A4 (en) | NEW VACCINES AGAINST MULTIPLE SUBTYPES OF THE DENGUE VIRUS | |
| GB201301119D0 (en) | Viral vaccines | |
| SG11201507455WA (en) | Hepatitis b virus vaccines | |
| TWM475510U (en) | Radical engine | |
| ZA201506581B (en) | Acellular pertussis vaccine | |
| GB201314063D0 (en) | Virus | |
| GB201306812D0 (en) | Virus | |
| GB201320646D0 (en) | Vaccine | |
| GB201315556D0 (en) | Vaccine |